GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AdAlta Ltd (ASX:1AD) » Definitions » 1-Year ROIIC %

AdAlta (ASX:1AD) 1-Year ROIIC % : 59.32% (As of Jun. 2024)


View and export this data going back to 2016. Start your Free Trial

What is AdAlta 1-Year ROIIC %?

1-Year Return on Invested Incremental Capital (1-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 1-year. AdAlta's 1-Year ROIIC % for the quarter that ended in Jun. 2024 was 59.32%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for AdAlta's 1-Year ROIIC % or its related term are showing as below:

ASX:1AD's 1-Year ROIIC % is ranked better than
71.03% of 1443 companies
in the Biotechnology industry
Industry Median: -8.23 vs ASX:1AD: 59.32

AdAlta 1-Year ROIIC % Historical Data

The historical data trend for AdAlta's 1-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AdAlta 1-Year ROIIC % Chart

AdAlta Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
1-Year ROIIC %
Get a 7-Day Free Trial 68.39 -156.60 383.01 -37.26 -

AdAlta Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
1-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 383.01 22.67 -37.26 59.32 -

Competitive Comparison of AdAlta's 1-Year ROIIC %

For the Biotechnology subindustry, AdAlta's 1-Year ROIIC %, along with its competitors' market caps and 1-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AdAlta's 1-Year ROIIC % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, AdAlta's 1-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where AdAlta's 1-Year ROIIC % falls into.



AdAlta 1-Year ROIIC % Calculation

AdAlta's 1-Year ROIIC % for the quarter that ended in Jun. 2024 is calculated as:

1-Year ROIIC %=1-Year Incremental Net Operating Profit After Taxes (NOPAT)**/1-Year Incremental Invested Capital
=( -7.062 (Jun. 2024) - -8.341 (Jun. 2023) )/( 1.952 (Jun. 2024) - 4.144 (Jun. 2023) )
=1.279/-2.192
=-58.35%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** TTM data of NOPAT and Invested Capital was used to calculate 1-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


AdAlta  (ASX:1AD) 1-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


AdAlta 1-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of AdAlta's 1-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


AdAlta Business Description

Traded in Other Exchanges
N/A
Address
2 Park Drive, Unit 15, Bundoora, VIC, AUS, 3083
AdAlta Ltd is engaged in drug discovery and development company developing protein therapeutics, known as i-bodies, for treating a wide range of human diseases. The i-body candidate, AD-214, is being developed for the treatment of idiopathic pulmonary fibrosis and other fibrotic diseases, for which current therapies are sub-optimal. Its pipeline includes Fibrosis, and CAR-T cancer therapeutics.

AdAlta Headlines

No Headlines